Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Relationships between genomic, cell cycle, and mutagenic responses of TK6 cells exposed to DNA damaging chemicals. [electronic resource] by
- Islaih, Mohammed
- Halstead, Bartley W
- Kadura, Ibrahim A
- Li, Baohui
- Reid-Hubbard, Jaclyn L
- Flick, Leah
- Altizer, Julie L
- Thom Deahl, J
- Monteith, David K
- Newton, Ronald K
- Watson, David E
Producer: 20051130
In:
Mutation research vol. 578
Availability: No items available.
|
|
17.
|
The Rat microRNA body atlas; Evaluation of the microRNA content of rat organs through deep sequencing and characterization of pancreas enriched miRNAs as biomarkers of pancreatic toxicity in the rat and dog. [electronic resource] by
- Smith, Aaron
- Calley, John
- Mathur, Sachin
- Qian, Hui-Rong
- Wu, Han
- Farmen, Mark
- Caiment, Florian
- Bushel, Pierre R
- Li, Jianying
- Fisher, Craig
- Kirby, Patrick
- Koenig, Erik
- Hall, David G
- Watson, David E
Producer: 20170829
In:
BMC genomics vol. 17
Availability: No items available.
|
|
18.
|
Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. [electronic resource] by
- Sobol, Robert W
- Watson, David E
- Nakamura, Jun
- Yakes, F Michael
- Hou, Esther
- Horton, Julie K
- Ladapo, Joseph
- Van Houten, Bennett
- Swenberg, James A
- Tindall, Kenneth R
- Samson, Leona D
- Wilson, Samuel H
Producer: 20020618
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 99
Availability: No items available.
|
|
19.
|
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. [electronic resource] by
- Kazda, Christof M
- Ding, Ying
- Kelly, Ronan P
- Garhyan, Parag
- Shi, Chunxue
- Lim, Chay Ngee
- Fu, Haoda
- Watson, David E
- Lewin, Andrew J
- Landschulz, William H
- Deeg, Mark A
- Moller, David E
- Hardy, Thomas A
Producer: 20171101
In:
Diabetes care vol. 39
Availability: No items available.
|
|
20.
|
Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249. [electronic resource] by
- Kazda, Christof M
- Ding, Ying
- Kelly, Ronan P
- Garhyan, Parag
- Shi, Chunxue
- Lim, Chay Ngee
- Fu, Haoda
- Watson, David E
- Lewin, Andrew J
- Landschulz, William H
- Deeg, Mark A
- Moller, David E
- Hardy, Thomas A
Producer: 20180108
In:
Diabetes care vol. 39
Availability: No items available.
|